3 Genomics Stocks to Unlock the Future of Medicine
Genomics stocks stand to surge in 2024 after the FDA approved the nation's first gene-editing therapeutic for clinical use.
Source: investorplace.com
Stay updated with breaking news from Recursion Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Genomics stocks stand to surge in 2024 after the FDA approved the nation's first gene-editing therapeutic for clinical use.
It isn't the first drugmaker to partner with the chipmaker, and it won't be the last.
Its positioning in biotech will likely take a long while to pay off.
Its positioning in biotech will likely take a long while to pay off.
In this article, we discuss the 11 most promising AI stocks according to hedge funds.